These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 1847526)

  • 1. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
    de Wied D; Elands J; Kovács G
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D; Gaffori O; Burbach JP; Kovács GL; van Ree JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior.
    Hirate K; Hirano M; Nakajima Y; Hiyama A; Maeda O; Asakura W
    Behav Brain Res; 1997 Feb; 83(1-2):205-8. PubMed ID: 9062685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
    De Wied D; Gaffori O; Van Ree JM; De Jong W
    Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonally active arginine-vasopressin suppresses endotoxin-induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment.
    Kovács GL; De Wied D
    Neuroendocrinology; 1983 Oct; 37(4):258-61. PubMed ID: 6355890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyretic effect of central arginine8-vasopressin treatment: V1 receptors specifically involved?
    Kovacs GL; Baars AM; De Wied D
    Life Sci; 1992; 50(21):1625-30. PubMed ID: 1315900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N alpha-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin.
    Kovács GL; Liu B; Burbach JP; Van Ree JM; De Wied D
    Eur J Pharmacol; 1989 Feb; 161(1):27-35. PubMed ID: 2721547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
    Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin.
    Inenaga K; Yamashita H
    J Physiol; 1986 Jan; 370():165-80. PubMed ID: 3007746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin but not vasopressin facilitates social recognition following injection into the medial preoptic area of the rat brain.
    Popik P; van Ree JM
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):555-60. PubMed ID: 1668316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D; Gaffori O; van Ree JM; de Jong W
    Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of vasotocin stimulation of phosphoinositide turnover in frog adrenal gland.
    Larcher A; Delarue C; Homo-Delarche F; Kikuyama S; Kupryszewski G; Vaudry H
    Endocrinology; 1992 Jan; 130(1):475-83. PubMed ID: 1309345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system effects of the neurohypophyseal hormones and related peptides.
    de Wied D; Diamant M; Fodor M
    Front Neuroendocrinol; 1993 Oct; 14(4):251-302. PubMed ID: 8258377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of ACTH4-10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats.
    Wan R; Diamant M; de Jong W; de Wied D
    Physiol Behav; 1992 Mar; 51(3):507-13. PubMed ID: 1326112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
    Lebrun C; Le Moal M; Koob GF; Bloom FE
    Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin enhances the clearance of beta-endorphin immunoreactivity from rat cerebrospinal fluid.
    Sweep CG; Boomkamp MD; Barna I; Logtenberg AW; Wiegant VM
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):191-200. PubMed ID: 2138399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vasopressin and other neuropeptides on rostral medullary sympathoexcitatory neurons 'in vitro'.
    Sun MK; Guyenet PG
    Brain Res; 1989 Jul; 492(1-2):261-70. PubMed ID: 2752300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells.
    Kusano E; Tian S; Umino T; Tetsuka T; Ando Y; Asano Y
    J Hypertens; 1997 Jun; 15(6):627-32. PubMed ID: 9218182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures.
    Kovács GL; Veldhuis HD; Versteeg DH; De Wied D
    Brain Res; 1986 Apr; 371(1):17-24. PubMed ID: 3708341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.